KD Logo

An Analysis of Mirum Pharmaceuticals Inc (MIRM)’s Potential Price Growth

Mirum Pharmaceuticals Inc’s recently made public that its SVP, GLOBAL CONTROLLER Howe Jolanda unloaded Company’s shares for reported $0.12 million on Nov 14 ’24. In the deal valued at $47.10 per share,2,500 shares were sold. As a result of this transaction, Howe Jolanda now holds 2,426 shares worth roughly $0.11 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Heron Patrick J bought 115 shares, generating $4,301 in total proceeds. Upon buying the shares at $37.40, the Director now owns 162,308 shares.

Before that, Heron Patrick J bought 230 shares. Mirum Pharmaceuticals Inc shares valued at $9,563 were divested by the Director at a price of $41.58 per share. As a result of the transaction, Heron Patrick J now holds 162,193 shares, worth roughly $7.15 million.

Stifel initiated its Mirum Pharmaceuticals Inc [MIRM] rating to a Buy in a research note published on April 17, 2024; the price target was $48. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who remained covering the stock and in mid December has reiterated a ‘”a Buy”‘ rating for it. Morgan Stanley started covering the stock on November 13, 2023. It rated MIRM as “an Overweight”.

Price Performance Review of MIRM

On Tuesday, Mirum Pharmaceuticals Inc [NASDAQ:MIRM] saw its stock jump 1.82% to $44.10. Over the last five days, the stock has lost -3.26%. Mirum Pharmaceuticals Inc shares have risen nearly 49.39% since the year began. Nevertheless, the stocks have risen 34.21% over the past one year. While a 52-week high of $48.89 was reached on 11/14/24, a 52-week low of $23.14 was recorded on 04/25/24. SMA at 50 days reached $41.61, while 200 days put it at $34.57.

Levels Of Support And Resistance For MIRM Stock

The 24-hour chart illustrates a support level at 43.14, which if violated will result in even more drops to 42.19. On the upside, there is a resistance level at 45.04. A further resistance level may holdings at 45.99. The Relative Strength Index (RSI) on the 14-day chart is 52.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.83, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 52.46%. Stochastics %K at 48.88% indicates the stock is a holding.

How much short interest is there in Mirum Pharmaceuticals Inc?

A steep rise in short interest was recorded in Mirum Pharmaceuticals Inc stocks on 2024-11-29, dropping by -0.13 million shares to a total of 6.72 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 6.85 million shares. There was a decline of -1.9%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on October 24, 2023 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating along with a $50 price target.

Most Popular